Intralesional TLR4 agonist treatment strengthens the organ defense against colonizing cancer cells in the brain. Blazquez R, Chuang HN, Wenske B, Trigueros L, et al. Oncogene 2022;41:5008-5019.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Blazquez R, Chuang HN, Wenske B, Trigueros L, et al. Intralesional TLR4 agonist treatment strengthens the organ defense against colonizing cancer cells in the brain. Oncogene 2022;41:5008-5019.
PMID: 36224342